Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

<div>(a) The ROC-AUC of HE4, CA125, and ROMA for the differentiation of stage I FIGO malignant tumors from nonmalignant adnexal tumors. FIGO: Fédération Internationale de Gynécologie et d’Obstétrique. (b) The ROC-AUC of HE4, CA125, and ROMA for the differentiation of epithelial ovarian cancer from nonmalignant adnexal tumors.</div>

Disease Markers

fig2

Figure 2

Figure 2: Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? 

Figure 2 | Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? 